Cargando…

Ketotherapeutics for neurodegenerative diseases

Alzheimer's disease (AD) and Parkinson's disease (PD) are, respectively, the most prevalent and fastest growing neurodegenerative diseases worldwide. The former is primarily characterized by memory loss and the latter by the motor symptoms of tremor and bradykinesia. Both AD and PD are pro...

Descripción completa

Detalles Bibliográficos
Autores principales:	Norwitz, Nicholas G., Jaramillo, Javier Gilbert, Clarke, Kieran, Soto, Adrian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Inc. 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7418707/ https://www.ncbi.nlm.nih.gov/pubmed/32854853 http://dx.doi.org/10.1016/bs.irn.2020.02.003

Ejemplares similares

Multi-Loop Model of Alzheimer Disease: An Integrated Perspective on the Wnt/GSK3β, α-Synuclein, and Type 3 Diabetes Hypotheses
por: Norwitz, Nicholas G., et al.
Publicado: (2019)

Why a d-β-hydroxybutyrate monoester?
por: Soto-Mota, Adrian, et al.
Publicado: (2020)

Exogenous d‐β‐hydroxybutyrate lowers blood glucose in part by decreasing the availability of L‐alanine for gluconeogenesis
por: Soto‐Mota, Adrian, et al.
Publicado: (2021)

Exogenous ketosis in patients with type 2 diabetes: Safety, tolerability and effect on glycaemic control
por: Soto‐Mota, Adrian, et al.
Publicado: (2021)

The Mechanisms by Which the Ketone Body D-β-Hydroxybutyrate May Improve the Multiple Cellular Pathologies of Parkinson's Disease
por: Norwitz, Nicholas G., et al.
Publicado: (2019)

A Company Is Only as Healthy as Its Workers: A 6-Month Metabolic Health Management Pilot Program Improves Employee Health and Contributes to Cost Savings
por: Norwitz, Nicholas G., et al.
Publicado: (2022)

A Ketone Ester Drink Enhances Endurance Exercise Performance in Parkinson’s Disease
por: Norwitz, Nicholas G., et al.
Publicado: (2020)

LRP5, Bone Density, and Mechanical Stress: A Case Report and Literature Review
por: Norwitz, Nicholas G., et al.
Publicado: (2019)

The potential contribution of impaired brain glucose metabolism to congenital Zika syndrome
por: Gilbert‐Jaramillo, Javier, et al.
Publicado: (2019)

Case Report: Hypercholesterolemia “Lean Mass Hyper-Responder” Phenotype Presents in the Context of a Low Saturated Fat Carbohydrate-Restricted Diet
por: Norwitz, Nicholas G., et al.
Publicado: (2022)

Elevated LDL Cholesterol with a Carbohydrate-Restricted Diet: Evidence for a “Lean Mass Hyper-Responder” Phenotype
por: Norwitz, Nicholas G, et al.
Publicado: (2021)

Reply to M Mindrum and J Moore et al
por: Ludwig, David S, et al.
Publicado: (2022)

The Lipid Energy Model: Reimagining Lipoprotein Function in the Context of Carbohydrate-Restricted Diets
por: Norwitz, Nicholas G., et al.
Publicado: (2022)

STING-Triggered CNS Inflammation in Human Neurodegenerative Diseases
por: Ferecskó, Alex S., et al.
Publicado: (2023)

Editorial: Blood Biomarkers of Neurodegenerative Diseases
por: Karikari, Thomas K., et al.
Publicado: (2022)

Astrocytes and microglia in neurodegenerative diseases: Lessons from human in vitro models
por: Franklin, Hannah, et al.
Publicado: (2021)

mTOR Mysteries: Nuances and Questions About the Mechanistic Target of Rapamycin in Neurodegeneration
por: Norwitz, Nicholas G., et al.
Publicado: (2020)

A Standard Lipid Panel Is Insufficient for the Care of a Patient on a High-Fat, Low-Carbohydrate Ketogenic Diet
por: Norwitz, Nicholas G., et al.
Publicado: (2020)

Nutrition as Metabolic Treatment for Anxiety
por: Norwitz, Nicholas G., et al.
Publicado: (2021)

Aquaporins and Neurodegenerative Diseases
por: Foglio, Eleonora, et al.
Publicado: (2010)

Neurofilamentopathy in Neurodegenerative Diseases
por: Liu, Quan, et al.
Publicado: (2011)

Genetic variants associated with neurodegenerative Alzheimer disease in natural models
por: Salazar, Claudia, et al.
Publicado: (2016)

Roles of Microglial Ion Channel in Neurodegenerative Diseases
por: Cojocaru, Alexandru, et al.
Publicado: (2021)

Neuroinflammation in neurodegenerative disease
por: Yamanaka, Koji
Publicado: (2023)

Dietary habits, lifestyle factors and neurodegenerative diseases
por: Popa-Wagner, Aurel, et al.
Publicado: (2019)

Proteotoxicity and Neurodegenerative Diseases
por: Ruz, Clara, et al.
Publicado: (2020)

Microglia in neurodegenerative diseases
por: Xu, Yu, et al.
Publicado: (2020)

Peroxiredoxins in Neurodegenerative Diseases
por: Szeliga, Monika
Publicado: (2020)

PPPM in neurodegenerative diseases
Publicado: (2011)

Genetics of neurodegenerative diseases
por: Pulst, Stefan M.
Publicado: (2016)

Mitoepigenetics and Neurodegenerative Diseases
por: Coppedè, Fabio, et al.
Publicado: (2019)

Mitochondria in neurodegenerative diseases
por: Lin, Fang, et al.
Publicado: (2019)

Synapses in neurodegenerative diseases
por: Bae, Jae Ryul, et al.
Publicado: (2017)

Neuregulins in Neurodegenerative Diseases
por: Ou, Guan-yong, et al.
Publicado: (2021)

Immunotherapies for Neurodegenerative Diseases
por: Mortada, Ibrahim, et al.
Publicado: (2021)

Biomarkers in Neurodegenerative Diseases
por: Ghosh, Arnab
Publicado: (2022)

Advances in Neurodegenerative Diseases
por: Siokas, Vasileios, et al.
Publicado: (2022)

Sphingolipids in neurodegenerative diseases
por: Pan, Xueyang, et al.
Publicado: (2023)

Advances in Neurodegenerative Diseases
por: Van Schependom, Jeroen, et al.
Publicado: (2023)

Lipids in Neurodegenerative Diseases
por: Chiurchiù, Valerio
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_rekga2r48giksevmpb71ngi8jb